Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted Effects.
Paillas S, Ladjohounlou R, Lozza C, Pichard A, Boudousq V, Jarlier M, Sevestre S, Le Blay M, Deshayes E, Sosabowski J, Chardès T, Navarro-Teulon I, Mairs RJ, Pouget JP. Paillas S, et al. Among authors: ladjohounlou r. Antioxid Redox Signal. 2016 Sep 10;25(8):467-84. doi: 10.1089/ars.2015.6309. Epub 2016 Jul 5. Antioxid Redox Signal. 2016. PMID: 27224059 Free PMC article.
Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy.
Ladjohounlou R, Lozza C, Pichard A, Constanzo J, Karam J, Le Fur P, Deshayes E, Boudousq V, Paillas S, Busson M, Le Blay M, Jarlier M, Marcatili S, Bardiès M, Bruchertseifer F, Morgenstern A, Torgue J, Navarro-Teulon I, Pouget JP. Ladjohounlou R, et al. Clin Cancer Res. 2019 Aug 1;25(15):4775-4790. doi: 10.1158/1078-0432.CCR-18-3295. Epub 2019 May 6. Clin Cancer Res. 2019. PMID: 31061069 Free article.
Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer.
Deshayes E, Ladjohounlou R, Le Fur P, Pichard A, Lozza C, Boudousq V, Sevestre S, Jarlier M, Kashani R, Koch J, Sosabowski J, Foster J, Chouin N, Bruchertseifer F, Morgenstern A, Kotzki PO, Navarro-Teulon I, Pouget JP. Deshayes E, et al. Among authors: ladjohounlou r. J Nucl Med. 2018 Aug;59(8):1234-1242. doi: 10.2967/jnumed.118.208611. Epub 2018 Apr 19. J Nucl Med. 2018. PMID: 29674421 Free article.
The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest.
Pichard A, Marcatili S, Karam J, Constanzo J, Ladjohounlou R, Courteau A, Jarlier M, Bonnefoy N, Patzke S, Stenberg V, Coopman P, Cartron G, Navarro-Teulon I, Repetto-Llamazares A, Heyerdahl H, Dahle J, Bardiès M, Pouget JP. Pichard A, et al. Among authors: ladjohounlou r. Leukemia. 2020 May;34(5):1315-1328. doi: 10.1038/s41375-019-0677-4. Epub 2019 Dec 13. Leukemia. 2020. PMID: 31836849 Free PMC article.
Realistic multi-cellular dosimetry for 177Lu-labelled antibodies: model and application.
Marcatili S, Pichard A, Courteau A, Ladjohounlou R, Navarro-Teulon I, Repetto-Llamazares A, Heyerdahl H, Dahle J, Pouget JP, Bardiès M. Marcatili S, et al. Among authors: ladjohounlou r. Phys Med Biol. 2016 Oct 7;61(19):6935-6952. doi: 10.1088/0031-9155/61/19/6935. Epub 2016 Sep 12. Phys Med Biol. 2016. PMID: 27617585
Novel platform for subcutaneous tumor irradiation in mice.
Mirjolet C, Ladjohounlou R, Baude J, Bessières I. Mirjolet C, et al. Among authors: ladjohounlou r. Methods Cell Biol. 2023;180:69-80. doi: 10.1016/bs.mcb.2023.06.004. Epub 2023 Jul 19. Methods Cell Biol. 2023. PMID: 37890933
11 results